In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae.

@article{Strigl2000InVA,
  title={In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae.},
  author={S. Strigl and Patricia M. Roblin and Tamara Reznik and Margaret R. Hammerschlag},
  journal={Antimicrobial agents and chemotherapy},
  year={2000},
  volume={44 4},
  pages={
          1112-3
        }
}
The in vitro activities of ABT 773, telithromycin (HMR 3647), azithromycin, clarithromycin, erythromycin, and levofloxacin were tested against 20 strains of Chlamydia pneumoniae. The MIC at which 90% of the isolates were inhibited and the minimal bactericidal concentration at which 90% of the isolates were killed by ABT 773 were 0.015 microg/ml (range, 0.008 to 0.015 microg/ml). ABT 773 was the most active antibiotic tested in this study. 

Tables and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 16 CITATIONS

The Ketolides

VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 10 REFERENCES

In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae

R. R. Reinert, A. Bryskier, R. Lüttiken
  • in Germany. Antimicrob. Agents Chemother
  • 1998
VIEW 1 EXCERPT

The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent.

  • The Journal of antimicrobial chemotherapy
  • 1998
VIEW 2 EXCERPTS